What most accurately describes the mechanism of action for tubocurarine in respiratory function?

• A. Stimulation of acetylcholine receptors
• B. Inhibition of cholinesterase activity
• C. Competitive antagonism at neuromuscular junction
• D. Direct muscle stimulation

Answer: (C)

Tubocurarine is a non-depolarizing neuromuscular blocker that works by competitively antagonizing acetylcholine at the neuromuscular junction. In this context, acetylcholine is a neurotransmitter that facilitates the transmission of nerve impulses to muscles, leading to their contraction. By blocking the binding of acetylcholine to its receptors on the motor end plate, tubocurarine prevents muscle contraction, which is particularly significant in respiratory muscles.

This mechanism is critical in scenarios where muscle paralysis is required, such as during surgical procedures or in critical care settings to manage airway maintenance and ventilation. The competitive nature of its antagonism means that higher concentrations of acetylcholine can potentially overcome this effect, unlike depolarizing neuromuscular blockers, which work through a different mechanism involving sustained depolarization of the muscle membrane.

The other options do not accurately describe the action of tubocurarine. Stimulation of acetylcholine receptors would promote muscle contraction, not block it. Inhibition of cholinesterase activity would lead to prolonged presence of acetylcholine at the receptor, which is contrary to the action of tubocurarine. Direct muscle stimulation is not how tubocurarine functions, as its role is strictly at